Control of α Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2α) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2α-Dependent Gene Expression and Cell Death

Molecular and Cellular Biology

Volumn 24, Issue 8, 2004, Pages 3415-3429

  Kazemi, Shirin ^a   Papadopoulou, Stavroula ^a   Li, Suiyang ^a,b   Su, Qiaozhu ^a   Wang, Shuo ^a   Yoshimura, Akihiko ^c   Matlashewski, Greg ^b   Dever, Thomas E ^d   Koromilas, Antonis E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 34; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INITIATION FACTOR 2; INITIATION FACTOR 2ALPHA; INTERFERON; PROTEIN E6; PROTEIN KINASE; PROTEIN KINASE R; SERINE; UNCLASSIFIED DRUG;

ALPHA CHAIN; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DEPHOSPHORYLATION; DIMERIZATION; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RNA TRANSLATION; SIGNAL TRANSDUCTION; STRESS; VIRUS INFECTION; VIRUS VIRULENCE; WART VIRUS;

AMINOCOUMARINS; ANTIGENS, DIFFERENTIATION; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; COUMARINS; DNA-BINDING PROTEINS; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN SUBUNITS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EUKARYOTA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 1842505312     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.8.3415-3429.2004     Document Type: Article

References (87)

1. Adamson, E. D., and D. Mercola. 2002. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol. 23:93-102.
2. Balachandran, S., C. N. Kim, W. C. Yeh, T. W. Mak, K. Bhalla, and G. N. Barber. 1998. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17:6888-6902.
3. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:1013-1018.
4. Beretta, L., M. Gahhay, R. Berger, S. M. Hanash, and N. Sonenberg. 1996. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12:1593-1596.
5. Beyaert, R., K. Heyninck, and S. Van Huffel. 2000, A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60:1143-1151.
6. Brush, M. H., D. C. Weiser, and S. Shenolikar. 2003. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Mol. Cell. Biol. 23:1292-1303.
7. Burgering, B. M., and G. J. Kops. 2002. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:352-360.
8. Burgert, H. G., Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windhielm, and A. Elsing. 2002. Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol. 269:273-318.
9. Cben, J. J. 2000. Heme-regulated eIF2α kinase, p. 529-546. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
10. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
11. Christopher, S. A., P. Diegeiman, C. W. Porter, and W. D. Kruger. 2002. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res. 62:6639-6644.
12. Clemens, M. J. 2001. Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. Prog. Mol. Subcell. But. 27:57-89.
13. Clemens, M. J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503-524.
14. Corbett, J. M., M. J. Dunn, A. Posch, and A. Gorg. 1994. Positional reproducibility of protein spots in two-dimensional polyacrylamide gel electrophoresis using immobilised pH gradient isoelectric focusing in the first dimension: an interlaboratory comparison. Electrophoresis 15:1205-1211.
15. Dell, G., and K. Gaston. 2001. Human papillomaviruses and their role in cervical cancer. Cell Mol. Life Sci. 58:1923-1942.
16. Dever, T. E. 2002. Gene-specific regulation by general translation factors. Cell 108:545-556.
17. Donze, O., J. Dostie, and N. Sonenberg. 1999. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology 256:322-329.
18. Dreyling, M. H., D. Roulston, S. K. Bohlander, J. Vardiman, and O. I. Olopade. 1998. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22:72-78.
19. Dunn, M. J., and J. M. Corbett. 1996. Two-dimensional polyacrylamide gel electrophoresis. Methods Enzymol. 271:177-203.
20. Espert, L., G. Degols, C. Gongora, D. Blondel, B. R. Williams, R. H. Silverman, and N. Mechti. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278:16151-16158.
21. Gale, M., Jr., S. L. Tan, and M. G. Katze. 2000. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:239-280.
22. Gbosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
23. Gu, Z., D. Pim, S. Labrecque, L. Banks, and G. Matlashewski. 1994. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. Oncogene 9:629-633.
24. Guccione, E., P. Massimi, A. Bernat, and L. Banks. 2002. Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 293:20-25.
25. Harding, H. P., M. Calfon, F. Urano, I. Novoa, and D. Ron. 2002. Transcriptional and translational control in the Mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18:575-599.
26. Harding, H. P., I. Novoa, Y. Zhang, H. Zeng, R. Wek, M. Schapira, and D. Ron. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6:1099-1108.
27. 134.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:84-90.
28. Hershey, J. W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755.
29. Hirt, R. P., S. Muller, T. M. Emhley, and G. H. Coombs. 2002, The diversity and evolution of thioredoxin reductase: new perspectives. Trends Parasitol. 18:302-308.
30. Ishikawa, H., A. P. Heaney, R. Yu, G. A. Horwitz, and S. Melmed. 2001. Human pituitary tumor-transforming gene induces angiogenesis. J. Clin. Endocrinol. Metab. 86:867-874.
31. Ishikawa, S., M. Kai, M. Tamari, Y. Takei, K. Takeuchi, H. Bandou, Y. Yamane, M. Ogawa, and Y. Nakamura. 1997. Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line. DNA Res. 4:35-43.
32. Jagus, R., B. Joshi, and G. N. Barber. 1999. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 31:123-138.
33. Kastner, P., and S. Chan. 2001. Function of RARα during the maturation of neutrophils. Oncogene 20:7178-7185.
34. Katze, M. G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:75-78.
35. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immonul. 2:675-687.
36. Kaufman, R. J. 2000. Double-stranded RNA-activated protein kinase PKR, p. 503-527. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control of gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Kehmeier, E., H. Ruhl, B. Voland, M. C. Stoppler, E. Androphy, and H. Stoppler. 2002. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 299:72-87.
38. Kimball, S. R. 2001. Regulation of translation initiation by amino acids in eukaryotic cells. Prog. Mol. Subcell. Biol. 26:155-184.
39. Kirchboff, S., A. E. Koromilas, F. Schaper, M. Grashoff, N. Sonenberg, and H. Hauser. 1995. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11:439-445.
40. Kirfel, J., T. M. Magin, and J. Reichelt. 2003. Keratins: a structural scaffold with emerging functions. Cell. Mol. Life Sci. 60:56-71.
41. Koromilas, A. E., S. Li, and G. Matlashewski. 2001. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12:157-170.
42. Kumar, A., Y. L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B. R. Williams. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16:406-416.
43. Leib, D. A. 2002. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immumol. 269:171-185.
44. Leone, P. E., M. Mendiola, J. Alonso, C. Mino, and A. Pestana. 2003. Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker. BMC Cancer 3:6.
45. Li, S., and A. E. Koromilas. 2001. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J. Biol. Chem. 276:13881-13890.
46. Li, S., S. Labrecque, M. C. Gauzzi, A. R. Cuddihy, A. H. Wong, S. Pellegrini, G. J. Matlashewski, and A. E. Koromilas. 1999. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727-5737.
47. Li, S., K. Nagai, and A. E. Koromilas. 2000. A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes. Eur. J. Biochem. 267:1598-1606.
48. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
49. Munger, K. 2002. The role of human papillomaviruses in human cancers. Front. Biosci. 7:d641-d649.
50. Munger, K., and P. M. Howley. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228.
51. Nanbo, A., and K. Takada. 2002. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. Rev. Med. Virol. 12:321-326.
52. Neubig, R. R., and D. P. Siderovski. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1:187-197.
53. Novak, J. P., R. Sladek, and T. J. Hudson. 2002. Characterization of variability in large-scale gene expression data: implications for study design. Genomics 79:104-113.
54. Novoa, I., H. Zeng, H. P. Harding, and D. Ron. 2001. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α. J. Cell Biol. 153:1011-1022.
55. Novoa, I., Y. Zhang, H. Zeng, R. Jungreis, H. P. Harding, and D. Ron. 2003. Stress-induced gene expression requires programmed recovery from translational repression. EMBO J. 22:1180-1187.
56. Olofsson, B. 1999. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell. Signal. 11:545-554.
57. Pataer, A., S. A. Vorburger, G. N. Barber, S. Chada, A. M. Mhashilkar, H. Zou-Yang, A. L. Stewart, S. Balachandran, J. A. Roth, K. K. Hunt, and S. G. Swisher. 2002. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 62:2239-2243.
58. Payton, M., and S. Coats. 2002. Cyclin E2, the cycle continues. Int. J. Biochem. Cell Biol. 34:315-320.
59. Perelman, B., N. Dafni, T. Naiman, D. Eli, M. Yaakov, T. L. Feng, S. Sinha, G. Weber, S. Khodaei, A. Sancar, I. Dotan, and D. Canaanl. 1997. Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus. Genomics 41:397-405.
60. Protopopov, A., V. Kashuha, V. I. Zaharovska, O. V. Muravenko, M. I. Lerman, G. Klein, and E. R. Zaharovsky. 2003. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res. 63:404-412.
61. Puthalakath, H., and A. Strasser. 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:505-512.
62. Rajan, P., S. Swaminathan, J. Zhu, C. N. Cole, G. Barber, M. J. Tevethia, and B. Thimmapaya. 1995. A novel translational regulation function for the simian virus 40 large-T antigen gene. J. Virol. 69:785-795.
63. Ramos-Morales, F., A. Dominguez, F. Romero, R. Luna, M. C. Multon, J. A. Pintor-Toro, and M. Tortolero. 2000. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19:403-409.
64. Ron, D. 2002. Translational control in the endoplasmic reticulum stress response. J. Clin. Investig. 110:1383-1388.
65. Roulston, A., R. C. Marcellus, and P. E. Branton. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577-628.
66. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
67. Sanchez, J. C., V. Rouge, M. Pisteur, F. Ravier, L. Tonella, M. Moosmayer, M. R. Wilkins, and D. F. Hochstrasser. 1997. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 18:324-327.
68. Sauane, M., R. V. Gopalkrishnan, D. Sarkar, Z. Z. Su, I. V. Lebedeva, P. Dent, S. Pestka, and P. B. Fisher. 2003. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14:35-51.
69. Scheuner, D., B. Song, E. McEwen, C. Liu, R. Laybutt, P. Gillespie, T. Saunders, S. Bonner-Weir, and R. J. Kaufman. 2001. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7:1165-1176.
70. Schramm, L., and N. Hernandez. 2002. Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16:2593-2620.
71. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
72. Sheikh, M. S., M. C. Hollander, and A. J. Fornance, Jr. 2000. Role of Gadd45 in apoptosis. Biochem. Pharmacol. 59:43-45.
73. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
74. Swaminathan, S., P. Rajan, O. Savinova, R. Jagus, and B. Thimmapaya. 1996. Simian virus 40 large-T bypasses the translational block imposed by the phosphorylation of eIF-2 alpha. Virology 219:321-323.
75. Tan, S. L., and M. G. Katze. 1999. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19:543-554.
76. Tan, S. L., S. U. Tareen, M. W. Melville, C. M. Blakely, and M. G. Katze. 2002. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. J. Biol. Chem. 277:36109-36117.
77. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
78. Ung, T. L., C. Cao, J. Lu, K. Ozato, and T. E. Dever. 2001. Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20:.3728-3737.
79. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331-367.
80. Warden, S. M., C. Richardson, J. O'Donnell, Jr., D. Stapleton, B. E. Kemp, and L. A. Witters. 2001. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 354:275-283.
81. Wong, A. H., J. E. Durhin, S. Li, T. E. Dever, T. Decker, and A. E. Koromilas. 2001. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J. Biol. Chem. 276:13727-13737.
82. Wood, Z. A., E. Schroder, H. J. Rohin, and L. B. Poole. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28:32-40.
83. Yao, X., A. Ahrieu, Y. Zheng, K. F. Sullivan, and D. W. Cleveland. 2000. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2:484-491.
84. Yodoi, J., H. Nakamura, and H. Masutani. 2002. Redox regulation of stress signals: possible roles of dendritic stellate TRX producer cells (DST cell types). Biol. Chem. 383:585-590.
85. Zapata, J. M., and J. C. Reed. 2002. TRAF1: lord without a RING. Sci. STKE 2002:PE27.
86. Zhu, S., A. Y. Sobolev, and R. C. Wek. 1996. Histidyl-tRNA synthetase-related sequences in GCN2 protein kinase regulate in vitro phosphorylation of eIF-2. J. Biol. Chem. 271:24989-24994.
87. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.